These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10480255)

  • 1. Introduction of the gene amplification technique to decrease the risk of hepatitis C virus transmission by plasma products.
    Branović K; Forcis D; Kosutic-Gulija T; Santak M; Zgorelec R; Mazuran R
    J Chromatogr A; 1999 Aug; 852(1):305-12. PubMed ID: 10480255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hepatitis C virus RNA in anti-HCV negative plasma pools in Croatia.
    Forcić D; Zgorelec R; Branović K; Kosutić-Gulija T; Santak M; Mazuran R
    Transfus Apher Sci; 2001 Jun; 24(3):269-78. PubMed ID: 11791702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive PCR method for detecting HCV RNA in plasma pools, blood products, and single donations.
    Saldanha J; Minor P
    J Med Virol; 1994 May; 43(1):72-6. PubMed ID: 8083652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assays for viral sequences and their value in validation of viral elimination.
    Saldanha J
    Dev Biol Stand; 1993; 81():231-6. PubMed ID: 8174807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of blood donations by hepatitis C virus polymerase chain reaction (HCV-PCR) improves safety of blood products by window period reduction.
    Hitzler WE; Runkel S
    Clin Lab; 2001; 47(5-6):219-22. PubMed ID: 11405599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
    Roth WK; Weber M; Seifried E
    Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood.
    Sun R; Schilling W; Jayakar H; Ku J; Wang J; Rosenstraus M; Spadoro J
    Transfusion; 1999 Oct; 39(10):1111-9. PubMed ID: 10532606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective.
    Loubière S; Rotily M; Durand-Zaleski I; Costagliola D
    Vox Sang; 2001 May; 80(4):199-204. PubMed ID: 11438026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results.
    Wendel S; Levi JE; Takaoka DT; Silva IC; Castro JP; Torezan-Filho MA; Ghaname J; Gioachini R; Brandão J; Durigon EL
    Rev Inst Med Trop Sao Paulo; 2007; 49(3):177-85. PubMed ID: 17625696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.
    Candotti D; Richetin A; Cant B; Temple J; Sims C; Reeves I; Barbara JA; Allain JP
    Transfusion; 2003 Feb; 43(2):215-25. PubMed ID: 12559017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection.
    Legler TJ; Riggert J; Simson G; Wolf C; Humpe A; Munzel U; Uy A; Köhler M; Heermann KH
    Transfusion; 2000 Oct; 40(10):1192-7. PubMed ID: 11061854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
    Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C
    J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.
    Candotti D; Temple J; Owusu-Ofori S; Allain JP
    J Virol Methods; 2004 Jun; 118(1):39-47. PubMed ID: 15158067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay.
    Mercier B; Burlot L; Férec C
    J Virol Methods; 1999 Jan; 77(1):1-9. PubMed ID: 10029319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biological screening of viruses important to transfusion medicine].
    Wolff C; Hörnschemeyer D; Skurtopulos M; Petersen N; Beyer J; Seidel K; Mutz A; Kleesiek K
    Beitr Infusionsther Transfusionsmed; 1994; 32():102-9. PubMed ID: 9480064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with PCR screening.
    Sun R; Jayakar H; Yeh S; Mendoza M; Wisbeski MH; Iszczyszyn W; Dragon EA
    Dev Biol (Basel); 2000; 102():81-91. PubMed ID: 10794093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.